GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent
GE HealthCare has dosed the first patient in its Phase 2/3 LUMINA…
GE HealthCare broadens its deep learning CT portfolio with FDA clearance of True Definition DL
GE HealthCare has received clearance from the U.S. Food and Drug Administration…
GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance
GE HealthCare has received FDA clearance for its Photonova Spectra photon-counting CT…
University of South Florida Simulation Center Installs GE HealthCare Allia Moveo System
The University of South Florida’s CAMLS has become the first in Florida…
Dubai to host the world’s largest healthcare event with record international exhibitors and visitors
World Health Expo (WHX) in Dubai, formerly Arab Health, and World Health…
Dubai Health and GE HealthCare to enhance Point-of-Care Ultrasound (POCUS) education and practice in the MENA region
Dubai Health and GE HealthCare, a leading global medical technology and digital…
FDA Approves Updated Label for GE Healthcare’s Vizamyl to Enhance Alzheimer’s Diagnosis and Therapy Monitoring
GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has…
GE HealthCare Debuts SIGNA™ Sprint: A Breakthrough in 1.5T MRI Imaging
May 12, 2025 – HonoluluAt the 2025 International Society for Magnetic Resonance…
Shaping the Future of Healthcare: GE Healthcare’s Impact at Arab Health
Meet Konstantinos Deligiannis, President of GE HealthCare in Eurasian African Growth Markets,…
Alfred Health becomes first in southern hemisphere to adopt GE HealthCare’s command center
December 2024- GE HealthCare announced that Alfred Health in Melbourne will be…